New research has confirmed the association between perioperative blood transfusion and development of new anti–human leukocyte antigen (HLA) antibodies and donor-specific antibodies (DSAs) within the first year of lung transplantation in adults.
This relationship, the researchers said, implies a greater chance of postoperative complications, including chronic lung allograft dysfunction, among patients who undergo blood transfusion during lung transplantation.